National Patient Safety Board Act

Summary#

The National Patient Safety Board Act of 2026 would create a new law and establish a board inside the Department of Health and Human Services (HHS); it does not amend a named existing Act. Its stated goal is to prevent and reduce patient safety events, but that goal is not a guaranteed result. The bill was introduced and referred to House committees; it is not law.

  • The board would have five members appointed by the President. It would oversee three divisions and a public-private team that develops patient-safety measures and solutions.
  • The board must review division reports, make them public within one year after a study begins, undergo annual audits, and send annual progress reports to Congress.
  • The research division must analyze patient-level data, including by race, ethnicity, gender, facility, age, social factors, and location. HHS and Veterans Affairs (VA) offices and agencies must provide requested data; outside public and private entities may opt in to data sharing.
  • The research division must run a system where people can report events anonymously or by name and receive a response. The bill does not require people or health care organizations to report events.
  • The Study Division may conduct or support studies. Study teams need permission from each health care organization involved to enter facilities and communicate with people there.
  • Board publications cannot identify patients, providers, or care settings. They generally cannot be used as evidence of liability in civil damages cases, and HHS cannot use the board’s work to punish providers.

What it means for you#

  • Patients, families, providers, and other members of the public: You could report a patient safety event through the required system, anonymously or not, and receive a response. The bill does not set a response deadline or require you to report.
  • Health care organizations and workers: A study team would need the organization’s permission to enter its facilities and communicate with staff, providers, patients, vendors, suppliers, contractors, equipment manufacturers, or board members. Employees who cooperate would receive protection against discharge or discrimination under a referenced federal law.
  • Federal agencies: The board must include representatives with patient-safety expertise from AHRQ, CDC, CMS, VA, the Office of the National Coordinator for Health Information Technology, Indian Health Service, HHS’s Office of Minority Health, HRSA, SAMHSA, FDA, NIH, and the U.S. Preventive Services Task Force. The team must also include private-sector representatives for providers (including organized labor), health care organizations, patients, families, caregivers, payors, suppliers, vendors, manufacturers, measurement developers, and data technology experts.
  • HHS and VA: Their secretaries must publish responses to final study recommendations within 90 days. The board cannot decide anyone’s rights or liability for an event.
  • State and local entities and other outside organizations: They could choose to share data through agreements; the bill does not require them to do so.

Money#

No cost estimate is available in the supplied material.

  • The bill requires the board to have three divisions and a public-private team, and allows the chair to appoint staff. It gives no staffing numbers, funding amount, or specific appropriation.
  • It does not set fees, fines, or a new tax. The cost of creating and operating the board and data systems is not stated.

What is unclear#

  • The bill does not set a start date, describe how the board will be funded, or specify how many staff it will need.
  • It requires a response to reports but does not say what a response must contain or when it must be sent.
  • It does not explain how the board will choose which events to study, or how study findings and recommendations will affect health care organizations.
  • The bill uses two different names for the research division in parts of the data provisions. It is unclear whether these are drafting errors or refer to different divisions.
  • The bill requires privacy-law compliance and bars identifying details in publications, but does not explain how access to sensitive data will be overseen in practice.

Case for#

  • A national board could bring together federal agencies and private-sector expertise to study safety problems and their causes.
  • The bill calls for analysis across demographic and social categories, which could help identify patterns or disparities that broad totals might miss.
  • Public reports, annual audits, and published agency responses could make findings and recommendations more visible.
  • The limits on identifying information and punitive use could make it easier for people and organizations to cooperate with safety studies.

Case against#

  • The board and data systems require staff and ongoing work, but the bill provides no cost estimate or specific funding.
  • The board could obtain detailed patient-level data from HHS and VA agencies. The bill requires compliance with privacy law, but practical safeguards and oversight are not fully described.
  • The bill does not require outside entities to share data, and study teams need an organization’s permission to enter its facilities. These limits could leave gaps in what the board can study.
  • The board can require further studies or report revisions, but the bill does not set deadlines for those steps or explain how recommendations would be put into practice.